Rothschild Investment LLC Compugen LTD Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q4 2024
A detailed history of Rothschild Investment LLC transactions in Compugen LTD stock. As of the latest transaction made, Rothschild Investment LLC holds 203,900 shares of CGEN stock, worth $452,658. This represents 0.02% of its overall portfolio holdings.
Number of Shares
203,900
Previous 203,900
-0.0%
Holding current value
$452,658
Previous $369 Million
14.94%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding CGEN
# of Institutions
78Shares Held
13.1MCall Options Held
29.7KPut Options Held
12.7K-
Silverarc Capital Management, LLC1.62MShares$3.61 Million0.6% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.28MShares$2.84 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC1.09MShares$2.43 Million0.85% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$2.26 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD990KShares$2.2 Million0.06% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $192M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...